ARK Genomic Revolution ETF

Cboe: ARKG

The ARK Genomic Revolution ETF is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Funds investment theme of the genomics revolution.

Fact Sheet Prospectus & Information

Book Viewer

Book Viewer

Orders Accepted Total Volume Expand All | Select MIC to filter:
ARK Genomic Revolution ETF 314,634 185,363
Top of Book Last 10 Trades
Shares Price Time Price Shares
Asks 3,300 24.15 12:27:30 24.06 1
2,860 24.14 12:27:30 24.06 2
2,910 24.13 12:27:14 24.07 100
5,200 24.12 12:27:14 24.07 400
920 24.11 12:27:14 24.07 3
Bids 101 24.10 12:27:14 24.07 2
803 24.09 12:27:14 24.08 1
1,110 24.08 12:27:14 24.08 1
2,992 24.07 12:27:14 24.08 1
3,052 24.06 12:27:14 24.08 5
Last updated 12:29:26

About ARK Investment Management

ARK Investment Management LLC is a federally registered investment adviser and privately held investment firm. Specializing in thematic investing in disruptive innovation, the firm is rooted in over 40 years of experience in identifying and investing in innovations that should change the way the world works. Through its open research process, ARK identifies companies that it believes are leading and benefiting from cross-sector innovations such as robotics, energy storage, multiomic sequencing, artificial intelligence, and blockchain technology. ARK's investment strategies include Autonomous Technology and Robotics, Next Generation Internet, Genomic Revolution, Fintech Innovation, Space Exploration & Innovation, 3D Printing, Israel Innovative Technology, the overall ARK Disruptive Innovation Strategy, and the ARK Venture Fund. For more information about ARK, its offerings, and original research, please visit www.ark-invest.com.

http://ark-funds.com/